Effects of the beta adrenergic blocking agents, propranolol, KO592, and MJ-1999 on phenoxybenzamine blockade of norepinephrine.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D005260:Female; D008297:Male; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D011433:Propranolol; D009638:Norepinephrine